Error: Could not add to watchlist. X
+ Watchlist

Medivir AB

MVIRB:SS
Stockholm
67.00
SEK
1.00
1.47%
As of 6:59 AM EDT 5/24/2017
Open
68.00
Day Range
66.00 - 68.00
Volume
9,968
Previous Close
68.00
52Wk Range
41.86 - 87.13
1 Yr Return
56.87%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
68.00
Day Range
66.00 - 68.00
Volume
9,968
Previous Close
68.00
52Wk Range
41.86 - 87.13
1 Yr Return
56.87%
YTD Return
-19.97%
Current P/E Ratio (TTM)
-
Earnings per Share (SEK) (TTM)
-10.29
Market Cap (b SEK)
1.370
Shares Outstanding (m)
19.844
Price/Sales (TTM)
11.56
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.45%
% Price Change
+0.20%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.
Address
Lunastigen 7
Huddinge, 141 44
Sweden
Phone
46-8-546-831-00
  • Christine Lind
    Chief Executive Officer
  • Ola Burmark
    Chief Financial Officer
  • Richard Bethell
    Chief Scientific Officer
  • Daniel Eriksson
    Chief Information Officer
  • Asa Holmgren
    EVP:Strat Reg Affairs&Market
Show More